People Incorporated Common Stock (PPLI) Financials

People Incorporated Common Stock logo
$41.78 -0.74 (-1.74%)
As of 02:39 PM Eastern
Annual Income Statements for People Incorporated Common Stock

Annual Income Statements for People Incorporated Common Stock

This table shows People Incorporated Common Stock's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
247 23 270 598 -1,170 266 -540 -104
Consolidated Net Income / (Loss)
292 32 269 589 -1,192 258 -533 -101
Net Income / (Loss) Continuing Operations
292 82 290 591 -1,195 295 -573 -117
Total Pre-Tax Income
306 34 244 730 -1,526 393 -715 -82
Total Operating Income
36 5.73 -538 -137 -475 -238 -29 -97
Total Gross Profit
2,032 1,962 2,019 2,403 3,302 1,700 1,620 1,583
Total Revenue
2,533 2,510 2,765 3,700 5,235 2,919 2,622 2,393
Operating Revenue
2,533 2,510 2,765 3,700 5,235 2,919 2,622 2,393
Total Cost of Revenue
501 548 745 1,296 1,934 1,219 1,002 810
Operating Cost of Revenue
501 548 745 1,296 1,934 1,219 1,002 810
Total Operating Expenses
1,996 1,957 2,557 2,540 3,776 1,938 1,648 1,681
Selling, General & Admin Expense
570 573 745 797 992 519 499 419
Marketing Expense
1,099 1,118 1,165 1,362 1,915 803 738 728
Research & Development Expense
177 133 185 231 318 238 228 196
Depreciation Expense
42 55 69 75 131 81 41 38
Amortization Expense
107 74 127 75 308 288 142 93
Impairment Charge
0.00 3.32 265 0.00 113 9.00 0.00 207
Total Other Income / (Expense), net
270 29 782 867 -1,051 631 -686 16
Interest Expense
13 12 16 34 110 137 136 120
Interest & Investment Income
0.00 0.00 841 789 -724 722 -649 119
Other Income / (Expense), net
283 40 -43 112 -218 47 99 16
Income Tax Expense
13 -47 -46 139 -331 98 -142 35
Net Income / (Loss) Discontinued Operations
- -49 -21 -1.83 2.69 -37 40 15
Net Income / (Loss) Attributable to Noncontrolling Interest
46 9.29 -1.14 -8.56 -22 -7.63 6.57 2.56
Basic Earnings per Share
$2.90 $0.27 $3.16 $6.70 ($13.55) $3.07 ($6.49) ($1.30)
Weighted Average Basic Shares Outstanding
- - 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M
Diluted Earnings per Share
$2.90 $0.27 $2.97 $6.31 ($13.55) $2.97 ($6.49) ($1.30)
Weighted Average Diluted Shares Outstanding
- - 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M
Weighted Average Basic & Diluted Shares Outstanding
- - 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M

Quarterly Income Statements for People Incorporated Common Stock

This table shows People Incorporated Common Stock's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
45 -142 -244 -199 -217 211 -22 -77 -72 507 -687
Consolidated Net Income / (Loss)
45 -141 -237 -199 -215 211 -22 -76 -71 508 -685
Net Income / (Loss) Continuing Operations
49 -145 -276 -202 -258 191 -53 -76 -2.25 515 -685
Total Pre-Tax Income
96 -185 -362 -263 -321 266 -56 2.53 -18 692 -963
Total Operating Income
-63 -21 8.15 48 24 -7.49 -27 -113 -40 -14 -3.05
Total Gross Profit
365 381 399 475 294 282 275 451 263 280 275
Total Revenue
624 634 642 721 482 443 447 646 423 437 431
Operating Revenue
624 634 642 721 482 443 447 646 423 437 431
Total Cost of Revenue
259 253 243 247 187 161 172 195 160 157 156
Operating Cost of Revenue
259 253 243 247 187 161 172 195 160 157 156
Total Operating Expenses
428 403 391 427 270 290 303 564 303 294 278
Selling, General & Admin Expense
127 126 109 137 43 96 108 106 104 114 97
Marketing Expense
188 177 183 190 157 130 130 173 133 121 119
Research & Development Expense
63 53 54 58 36 34 34 46 40 34 34
Depreciation Expense
13 9.12 8.88 10 11 7.27 8.24 8.59 7.31 7.50 9.23
Amortization Expense
37 37 36 32 22 22 23 23 19 19 19
Total Other Income / (Expense), net
159 -164 -371 -312 -345 273 -29 116 22 706 -960
Interest Expense
35 34 35 32 28 37 28 27 26 26 26
Interest & Investment Income
164 -179 -346 -287 -324 307 17 119 34 722 -1,120
Other Income / (Expense), net
30 50 10 7.71 7.63 2.80 -18 24 14 11 186
Income Tax Expense
47 -40 -86 -62 -62 74 -3.11 78 -16 177 -278
Net Income / (Loss) Discontinued Operations
-4.47 3.23 39 2.30 44 19 31 -0.03 -68 -6.90 -0.16
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.06 0.77 6.27 -0.41 2.24 -0.82 0.14 1.00 1.21 0.99 2.43
Basic Earnings per Share
$0.52 ($1.71) ($2.93) ($2.37) ($2.64) $2.64 ($0.27) ($1.03) ($0.94) $6.78 ($9.15)
Weighted Average Basic Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M
Diluted Earnings per Share
$0.51 ($1.71) ($2.93) ($2.36) ($2.64) $2.57 ($0.27) ($0.96) ($0.94) $6.68 ($9.15)
Weighted Average Diluted Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M
Weighted Average Basic & Diluted Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M

Annual Cash Flow Statements for People Incorporated Common Stock

This table details how cash moves in and out of People Incorporated Common Stock's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
254 -46 2,634 -3,027 -690 -291 945 -820
Net Cash From Operating Activities
369 275 113 119 -83 77 192 61
Net Cash From Continuing Operating Activities
369 275 113 119 -83 77 192 64
Net Income / (Loss) Continuing Operations
292 82 290 591 -1,195 295 -573 -117
Consolidated Net Income / (Loss)
292 32 269 589 -1,192 258 -533 -101
Net Income / (Loss) Discontinued Operations
- -49 -21 -1.83 2.69 -37 40 15
Depreciation Expense
42 55 69 75 131 81 41 38
Amortization Expense
107 74 127 75 308 288 142 93
Non-Cash Adjustments To Reconcile Net Income
-76 181 -228 -701 1,335 -592 682 164
Changes in Operating Assets and Liabilities, net
3.15 -117 -144 79 -661 5.67 -99 -113
Net Cash From Discontinued Operating Activities
- - - - - - - -2.76
Net Cash From Investing Activities
-45 -250 -1,872 -2,908 -495 -41 327 -405
Net Cash From Continuing Investing Activities
-45 -250 -1,872 -2,908 -495 -41 327 -405
Purchase of Property, Plant & Equipment
-55 -95 -61 -90 -140 -94 -15 -19
Acquisitions
-66 -28 -685 -2,700 -244 0.00 0.00 -427
Purchase of Investments
-109 -254 -1,671 -24 -237 -547 -222 0.00
Sale of Property, Plant & Equipment
- - 0.00 1.22 9.78 29 13 17
Divestitures
- 166 26 16 91 11 177 11
Sale and/or Maturity of Investments
171 -30 530 225 19 549 389 14
Other Investing Activities, net
13 -9.09 -12 -336 6.12 9.90 -15 -1.59
Net Cash From Financing Activities
-198 127 4,203 1,116 -113 -206 -77 -451
Net Cash From Continuing Financing Activities
-198 127 4,203 1,116 -113 -206 -77 -451
Repayment of Debt
-19 -20 -33 -262 -26 -30 -70 -1,447
Repurchase of Common Equity
0.00 -57 -64 -35 -93 -166 0.00 -315
Issuance of Debt
2.50 0.00 500 1,600 0.00 0.00 7.96 1,391
Other Financing Activities, net
-186 229 2,395 -156 -27 -11 -15 -80
Effect of Exchange Rate Changes
- - - - - - - 0.76
Other Net Changes in Cash
127 -199 190 -1,354 - -121 502 -30

Quarterly Cash Flow Statements for People Incorporated Common Stock

This table details how cash moves in and out of People Incorporated Common Stock's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
209 391 213 132 -639 -65 -88 -29 133 -50 194
Net Cash From Operating Activities
40 20 64 68 -2.69 -2.75 30 37 15 -11 25
Net Cash From Continuing Operating Activities
40 20 64 68 -27 -2.75 30 37 9.96 46 50
Net Income / (Loss) Continuing Operations
49 -145 -276 -202 -258 211 -22 -76 -2.25 518 -685
Consolidated Net Income / (Loss)
45 -141 -237 -199 -215 211 -22 -76 -71 508 -685
Net Income / (Loss) Discontinued Operations
-4.47 3.23 39 2.30 44 - - -0.03 -68 -9.67 -0.16
Depreciation Expense
13 9.12 8.88 10 11 7.98 9.00 8.59 7.31 7.50 9.23
Amortization Expense
37 37 36 32 22 23 24 23 19 19 19
Non-Cash Adjustments To Reconcile Net Income
-163 163 369 312 284 -261 38 101 -10 -730 954
Changes in Operating Assets and Liabilities, net
104 -44 -74 -85 -87 16 -18 -20 -3.99 181 -273
Net Cash From Investing Activities
185 59 58 25 -375 1.32 3.26 -33 261 -11 185
Net Cash From Continuing Investing Activities
185 59 58 25 -375 1.32 3.26 -33 261 -11 185
Purchase of Property, Plant & Equipment
-2.91 -3.45 -3.40 -5.26 -4.14 -4.46 -4.88 -5.21 -7.96 -11 -6.19
Divestitures
160 2.50 11 3.61 10 -0.24 - 1.50 303 -0.04 4.54
Sale and/or Maturity of Investments
138 135 90 27 5.25 3.24 3.46 1.99 0.00 0.04 185
Other Investing Activities, net
1.20 -1.20 -15 0.05 0.13 2.66 0.67 -4.92 2.60 0.04 1.21
Net Cash From Financing Activities
-16 -8.20 -13 -40 -234 -65 -120 -32 -141 -18 -28
Net Cash From Continuing Financing Activities
-16 -8.20 -13 -40 -234 -65 -120 -32 -141 -18 -28
Repayment of Debt
-7.65 -7.52 -7.56 -47 -9.41 -1,426 -8.02 -3.96 -6.12 -8.45 -6.16
Issuance of Common Equity
- - - - 0.00 - - - 6.54 1.95 0.61
Other Financing Activities, net
-8.25 -0.68 -5.69 -0.36 -45 -9.50 -12 -13 -18 -1.45 -23

Annual Balance Sheets for People Incorporated Common Stock

This table presents People Incorporated Common Stock's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
4,097 9,162 12,303 10,394 10,371 9,689 7,195
Total Current Assets
1,229 4,119 3,076 2,561 2,241 2,485 1,545
Cash & Equivalents
840 3,366 2,119 1,417 1,297 1,382 941
Accounts Receivable
182 258 696 608 537 483 410
Other Current Assets
152 140 242 297 257 125 98
Other Current Nonoperating Assets
- 130 - - - 495 96
Plant, Property, & Equipment, net
305 275 571 511 455 313 284
Total Noncurrent Assets
2,563 4,767 8,656 7,322 7,675 6,890 5,366
Long-Term Investments
348 298 328 2,496 3,303 2,681 2,811
Goodwill
1,617 1,660 3,227 3,030 3,024 1,993 1,508
Intangible Assets
350 395 1,415 1,170 875 554 394
Other Noncurrent Operating Assets
248 2,148 3,687 626 473 325 223
Other Noncurrent Nonoperating Assets
- 267 - - - 1,337 429
Total Liabilities & Shareholders' Equity
4,097 9,162 12,303 10,394 10,371 9,689 7,195
Total Liabilities
1,048 1,779 4,535 3,794 3,583 3,384 2,406
Total Current Liabilities
585 751 1,382 1,080 950 886 561
Short-Term Debt
14 0.00 30 30 30 35 25
Accounts Payable
72 89 203 133 106 54 30
Accrued Expenses
320 340 983 760 672 509 391
Current Deferred Revenue
179 138 165 157 143 57 19
Other Current Nonoperating Liabilities
- 184 - - - 232 96
Total Noncurrent Liabilities
463 1,028 3,153 2,714 2,632 2,498 1,845
Long-Term Debt
232 712 2,046 2,020 1,993 1,435 1,401
Noncurrent Deferred & Payable Income Tax Liabilities
44 79 386 76 165 154 209
Other Noncurrent Operating Liabilities
180 234 721 618 475 373 226
Other Noncurrent Nonoperating Liabilities
- 2.97 - - - 536 8.66
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
44 232 19 27 33 25 25
Total Equity & Noncontrolling Interests
3,005 7,151 7,749 6,573 6,755 6,279 4,764
Total Preferred & Common Equity
2,535 6,598 7,175 5,932 6,078 5,578 4,734
Total Common Equity
2,535 6,598 7,175 5,932 6,078 5,578 4,734
Common Stock
0.00 5,910 6,266 6,295 6,340 6,381 5,960
Retained Earnings
0.00 694 905 -265 0.92 -539 -643
Treasury Stock
- - 0.00 -85 -252 -252 -571
Accumulated Other Comprehensive Income / (Loss)
-12 -6.17 4.40 -13 -11 -11 -12
Noncontrolling Interest
470 553 574 641 677 701 30

Quarterly Balance Sheets for People Incorporated Common Stock

This table presents People Incorporated Common Stock's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
10,549 10,018 10,360 10,204 9,837 7,187 7,360 7,188 6,820 7,520 6,562
Total Current Assets
2,198 2,212 2,311 2,368 2,401 1,694 1,602 1,515 1,551 1,552 1,756
Cash & Equivalents
1,327 1,252 1,507 1,602 1,720 1,159 1,094 1,005 1,112 1,113 1,319
Accounts Receivable
522 519 464 490 478 392 376 397 329 329 336
Other Current Assets
234 267 204 189 178 143 132 113 109 108 101
Other Current Nonoperating Assets
- - - - - 0.00 0.00 0.00 0.00 1.74 0.03
Plant, Property, & Equipment, net
495 478 425 409 401 308 305 299 286 289 285
Total Noncurrent Assets
7,856 7,328 7,624 7,427 7,036 5,185 5,454 5,373 4,984 5,679 4,521
Long-Term Investments
432 432 3,458 3,278 2,978 2,339 2,635 2,653 2,878 3,599 2,469
Goodwill
3,033 3,022 2,879 2,879 2,882 1,993 1,993 1,993 1,508 1,508 1,508
Intangible Assets
1,062 1,000 830 794 758 531 508 484 375 358 339
Other Noncurrent Operating Assets
3,329 2,874 457 477 418 322 318 243 223 214 205
Other Noncurrent Nonoperating Assets
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
10,549 10,018 10,360 10,204 9,837 7,187 7,360 7,188 6,820 7,520 6,562
Total Liabilities
3,737 3,572 3,510 3,479 3,354 2,424 2,398 2,344 2,226 2,390 2,114
Total Current Liabilities
1,034 1,023 855 885 875 627 559 592 420 420 438
Short-Term Debt
30 30 34 39 43 42 21 23 25 25 25
Accounts Payable
128 144 84 77 80 47 48 43 36 32 35
Accrued Expenses
716 684 609 649 634 459 425 462 339 342 354
Current Deferred Revenue
161 166 128 121 117 79 65 64 21 17 23
Other Current Nonoperating Liabilities
- - - - - 0.00 0.00 0.00 0.00 4.01 2.18
Total Noncurrent Liabilities
2,703 2,549 2,655 2,594 2,479 1,797 1,839 1,752 1,806 1,969 1,675
Long-Term Debt
2,006 2,000 1,982 1,971 1,960 1,420 1,412 1,407 1,396 1,390 1,385
Noncurrent Deferred & Payable Income Tax Liabilities
178 61 211 172 85 73 135 107 193 373 95
Other Noncurrent Operating Liabilities
518 489 462 451 435 304 292 239 217 206 196
Other Noncurrent Nonoperating Liabilities
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
35 33 33 29 29 25 25 25 12 12 12
Total Equity & Noncontrolling Interests
6,778 6,412 6,817 6,696 6,455 4,737 4,938 4,818 4,582 5,118 4,436
Total Preferred & Common Equity
6,117 5,741 6,133 6,008 5,760 4,714 4,911 4,790 4,549 5,082 4,391
Total Common Equity
6,117 5,741 6,133 6,008 5,760 4,714 4,911 4,790 4,549 5,082 4,391
Common Stock
6,312 6,327 6,346 6,364 6,362 5,914 5,920 5,923 5,974 6,008 6,004
Retained Earnings
64 -327 46 -96 -340 -756 -544 -566 -715 -208 -896
Treasury Stock
-253 -252 -252 -252 -252 -433 -454 -555 -696 -704 -704
Accumulated Other Comprehensive Income / (Loss)
-6.90 -6.58 -6.89 -6.47 -9.61 -11 -11 -12 -14 -14 -14
Noncontrolling Interest
661 672 684 688 695 24 26 28 33 36 45

Annual Metrics And Ratios for People Incorporated Common Stock

This table displays calculated financial ratios and metrics derived from People Incorporated Common Stock's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% -0.91% 10.14% 33.82% 41.51% -44.24% -10.18% -8.73%
EBITDA Growth
0.00% -62.42% -318.62% 132.41% -303.67% 170.04% 42.07% -80.38%
EBIT Growth
0.00% -85.49% -1,355.33% 95.65% -2,646.82% 72.40% 136.55% -216.03%
NOPAT Growth
0.00% -60.20% -4,777.83% 82.62% -199.51% 46.32% 88.75% -239.69%
Net Income Growth
0.00% -88.99% 734.56% 119.29% -302.46% 121.66% -306.46% 80.97%
EPS Growth
0.00% -90.69% 1,000.00% 112.46% -314.74% 121.92% -318.52% 79.97%
Operating Cash Flow Growth
0.00% -25.47% -58.82% 4.87% -169.63% 193.39% 148.91% -68.16%
Free Cash Flow Firm Growth
0.00% 0.00% -20.76% -38.15% 172.97% -89.94% 443.67% -90.24%
Invested Capital Growth
0.00% 0.00% 89.68% 84.61% -39.05% -9.67% -34.82% -7.71%
Revenue Q/Q Growth
0.00% 0.00% 9.22% 13.89% 1.69% -35.89% -11.38% -34.50%
EBITDA Q/Q Growth
0.00% 0.00% -987.53% 231.27% -39.91% 479.11% -11.67% -85.29%
EBIT Q/Q Growth
0.00% 0.00% -150.06% 88.49% -25.11% 51.42% 463.47% -176.01%
NOPAT Q/Q Growth
0.00% 0.00% -85.25% -79.54% -1.23% 14.75% 74.78% -210.09%
Net Income Q/Q Growth
0.00% 0.00% 215.12% -45.91% -1.52% 428.44% -7,215.91% 54.91%
EPS Q/Q Growth
0.00% 0.00% 0.00% -47.63% 0.00% 0.00% -10,916.67% 51.85%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 234.76% -75.79% 57.06% -52.25% 12.48% -75.97%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -39.05% 202.62% 290.21% -49.74% -88.77%
Invested Capital Q/Q Growth
0.00% 0.00% 91.48% 62.62% -32.80% -38.62% -29.65% -6.55%
Profitability Metrics
- - - - - - - -
Gross Margin
80.22% 78.18% 73.04% 64.96% 63.06% 58.24% 61.77% 66.16%
EBITDA Margin
18.48% 7.01% -13.91% 3.37% -4.85% 6.09% 9.63% 2.07%
Operating Margin
1.41% 0.23% -19.45% -3.70% -9.07% -8.14% -1.09% -4.07%
EBIT Margin
12.58% 1.84% -20.99% -0.68% -13.23% -6.55% 2.66% -3.39%
Profit (Net Income) Margin
11.54% 1.28% 9.72% 15.92% -22.78% 8.85% -20.34% -4.24%
Tax Burden Percent
95.68% 93.78% 110.00% 80.70% 78.13% 65.72% 74.59% 123.88%
Interest Burden Percent
95.90% 74.25% -42.08% -2,894.56% 220.38% -205.62% -1,023.56% 101.05%
Effective Tax Rate
4.32% -137.98% -18.72% 19.04% 0.00% 24.98% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 1.30% -20.92% -1.95% -5.60% -4.17% -0.60% -2.68%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2.64% -62.82% -39.02% 63.40% -22.25% 15.48% -1.57%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.82% 26.07% 9.73% -11.00% 8.03% -7.55% 0.85%
Return on Equity (ROE)
0.00% 2.11% 5.15% 7.78% -16.60% 3.86% -8.15% -1.83%
Cash Return on Invested Capital (CROIC)
0.00% -198.70% -82.83% -61.41% 42.92% 5.99% 41.56% 5.34%
Operating Return on Assets (OROA)
0.00% 1.13% -8.75% -0.23% -6.10% -1.84% 0.70% -0.96%
Return on Assets (ROA)
0.00% 0.79% 4.05% 5.49% -10.51% 2.49% -5.32% -1.21%
Return on Common Equity (ROCE)
0.00% 1.76% 4.51% 7.07% -15.14% 3.46% -7.25% -1.70%
Return on Equity Simple (ROE_SIMPLE)
0.00% 1.27% 4.07% 8.21% -20.10% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
34 14 -638 -111 -332 -178 -20 -68
NOPAT Margin
1.35% 0.54% -23.09% -3.00% -6.35% -6.11% -0.77% -2.85%
Net Nonoperating Expense Percent (NNEP)
0.00% 3.94% 41.90% 37.07% -69.00% 18.09% -16.08% -1.11%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -3.85% -2.03% -0.26% -1.10%
Cost of Revenue to Revenue
19.78% 21.82% 26.96% 35.04% 36.94% 41.76% 38.23% 33.84%
SG&A Expenses to Revenue
22.49% 22.83% 26.96% 21.55% 18.95% 17.77% 19.03% 17.49%
R&D to Revenue
7.00% 5.28% 6.70% 6.24% 6.07% 8.15% 8.71% 8.19%
Operating Expenses to Revenue
78.80% 77.95% 92.49% 68.67% 72.13% 66.38% 62.86% 70.23%
Earnings before Interest and Taxes (EBIT)
319 46 -580 -25 -693 -191 70 -81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
468 176 -385 125 -254 178 253 50
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.45 1.63 0.67 0.61 0.55 0.64
Price to Tangible Book Value (P/TBV)
0.00 0.00 3.56 4.62 2.28 1.71 1.02 1.22
Price to Revenue (P/Rev)
0.00 0.00 5.85 3.16 0.75 1.28 1.18 1.27
Price to Earnings (P/E)
0.00 0.00 59.91 19.59 0.00 14.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.18%
Earnings Yield
0.00% 0.00% 1.67% 5.10% 0.00% 7.14% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 3.45 1.61 0.56 0.42 0.46 0.30
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 4.98 3.22 0.48 0.59 0.46 0.31
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 95.55 0.00 9.61 4.81 14.88
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 17.40 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 121.43 100.17 0.00 22.10 6.32 12.03
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.99 6.66 0.87 5.42
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.08 0.10 0.27 0.31 0.30 0.23 0.30
Long-Term Debt to Equity
0.00 0.08 0.10 0.26 0.31 0.29 0.23 0.29
Financial Leverage
0.00 -0.31 -0.41 -0.25 -0.17 -0.36 -0.49 -0.54
Leverage Ratio
0.00 1.34 1.27 1.42 1.58 1.55 1.53 1.52
Compound Leverage Factor
0.00 1.00 -0.53 -41.01 3.48 -3.19 -15.68 1.53
Debt to Total Capital
0.00% 7.46% 8.80% 21.09% 23.70% 22.96% 18.91% 22.94%
Short-Term Debt to Total Capital
0.00% 0.42% 0.00% 0.30% 0.35% 0.34% 0.45% 0.39%
Long-Term Debt to Total Capital
0.00% 7.04% 8.80% 20.79% 23.35% 22.62% 18.46% 22.55%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 15.60% 9.70% 6.02% 7.72% 8.06% 9.34% 0.89%
Common Equity to Total Capital
0.00% 76.94% 81.50% 72.89% 68.58% 68.98% 71.75% 76.17%
Debt to EBITDA
0.00 1.40 -1.85 16.66 -8.07 11.38 5.82 28.77
Net Debt to EBITDA
0.00 -5.36 8.26 -3.13 8.28 -15.33 -10.26 -47.32
Long-Term Debt to EBITDA
0.00 1.32 -1.85 16.42 -7.96 11.21 5.68 28.27
Debt to NOPAT
0.00 18.01 -1.12 -18.71 -6.17 -11.34 -73.23 -20.91
Net Debt to NOPAT
0.00 -69.04 4.98 3.52 6.33 15.28 129.17 34.40
Long-Term Debt to NOPAT
0.00 17.00 -1.12 -18.44 -6.08 -11.17 -71.48 -20.55
Altman Z-Score
0.00 0.00 6.09 2.11 1.04 0.99 0.96 1.11
Noncontrolling Interest Sharing Ratio
0.00% 16.86% 12.45% 9.09% 8.77% 10.30% 10.98% 7.05%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 2.10 5.49 2.23 2.37 2.36 2.80 2.75
Quick Ratio
0.00 1.84 5.13 2.05 2.10 2.09 2.10 2.51
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,093 -2,528 -3,492 2,548 256 1,394 136
Operating Cash Flow to CapEx
675.63% 289.53% 186.71% 133.61% -63.70% 120.46% 8,504.77% 3,515.61%
Free Cash Flow to Firm to Interest Expense
0.00 -175.84 -156.36 -101.92 23.13 1.87 10.27 1.13
Operating Cash Flow to Interest Expense
28.29 23.13 7.01 3.47 -0.75 0.56 1.42 0.51
Operating Cash Flow Less CapEx to Interest Expense
24.10 15.14 3.26 0.87 -1.93 0.10 1.40 0.50
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.61 0.42 0.34 0.46 0.28 0.26 0.28
Accounts Receivable Turnover
0.00 13.80 12.58 7.76 8.03 5.10 5.14 5.14
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 8.22 9.53 8.75 9.68 6.05 6.82 7.97
Accounts Payable Turnover
0.00 7.56 9.24 8.88 11.50 10.22 12.59 17.76
Days Sales Outstanding (DSO)
0.00 26.45 29.02 47.02 45.43 71.54 70.97 71.06
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 48.29 39.49 41.11 31.74 35.72 28.98 20.55
Cash Conversion Cycle (CCC)
0.00 -21.84 -10.48 5.91 13.70 35.83 41.99 50.51
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 2,107 3,996 7,378 4,497 4,062 2,648 2,444
Invested Capital Turnover
0.00 2.38 0.91 0.65 0.88 0.68 0.78 0.94
Increase / (Decrease) in Invested Capital
0.00 2,107 1,889 3,381 -2,881 -435 -1,414 -204
Enterprise Value (EV)
0.00 0.00 13,768 11,910 2,510 1,709 1,216 737
Market Capitalization
0.00 0.00 16,159 11,707 3,945 3,724 3,082 3,028
Book Value per Share
$0.00 $0.00 $77.31 $80.11 $66.76 $70.80 $64.66 $61.13
Tangible Book Value per Share
$0.00 $0.00 $53.23 $28.29 $19.49 $25.38 $35.12 $31.98
Total Capital
0.00 3,295 8,095 9,844 8,650 8,812 7,774 6,215
Total Debt
0.00 246 712 2,076 2,050 2,023 1,470 1,426
Total Long-Term Debt
0.00 232 712 2,046 2,020 1,993 1,435 1,401
Net Debt
0.00 -942 -3,177 -390 -2,103 -2,726 -2,593 -2,345
Capital Expenditures (CapEx)
55 95 61 89 130 64 2.26 1.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -182 -223 -414 -146 -126 252 48
Debt-free Net Working Capital (DFNWC)
0.00 658 3,368 1,725 1,511 1,320 1,634 1,008
Net Working Capital (NWC)
0.00 644 3,368 1,695 1,481 1,290 1,599 984
Net Nonoperating Expense (NNE)
-258 -19 -907 -700 860 -437 513 33
Net Nonoperating Obligations (NNO)
0.00 -942 -3,387 -390 -2,103 -2,726 -3,657 -2,345
Total Depreciation and Amortization (D&A)
149 130 196 150 439 369 183 131
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -7.26% -8.06% -11.19% -2.78% -4.33% 9.61% 2.01%
Debt-free Net Working Capital to Revenue
0.00% 26.20% 121.84% 46.62% 28.86% 45.22% 62.31% 42.14%
Net Working Capital to Revenue
0.00% 25.65% 121.84% 45.81% 28.29% 44.19% 60.98% 41.11%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $3.16 $6.70 ($13.55) $3.07 ($6.49) ($1.30)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.97 $6.31 ($13.55) $2.97 ($6.49) ($1.30)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 88.77M 89.76M 88.87M 85.97M 83.28M 76.91M
Normalized Net Operating Profit after Tax (NOPAT)
34 6.34 -191 -111 -253 -172 -20 77
Normalized NOPAT Margin
1.35% 0.25% -6.90% -3.00% -4.84% -5.88% -0.77% 3.22%
Pre Tax Income Margin
12.06% 1.37% 8.83% 19.73% -29.15% 13.46% -27.27% -3.42%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
24.40 3.88 -35.89 -0.74 -6.29 -1.39 0.51 -0.68
NOPAT to Interest Expense
2.63 1.15 -39.49 -3.24 -3.02 -1.30 -0.15 -0.57
EBIT Less CapEx to Interest Expense
20.21 -4.11 -39.65 -3.33 -7.47 -1.86 0.50 -0.69
NOPAT Less CapEx to Interest Expense
-1.56 -6.84 -43.24 -5.84 -4.20 -1.76 -0.16 -0.58
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 76.42% 1.59% 5.15% -0.10% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 253.24% 25.30% 11.16% -7.94% 64.12% 0.00% -310.48%

Quarterly Metrics And Ratios for People Incorporated Common Stock

This table displays calculated financial ratios and metrics derived from People Incorporated Common Stock's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
85,965,621.00 86,094,182.00 86,123,365.00 86,268,572.00 83,283,336.00 79,841,774.00 80,157,271.00 - 76,907,964.00 74,380,054.00 74,463,925.00
DEI Adjusted Shares Outstanding
85,965,621.00 86,094,182.00 86,123,365.00 86,268,572.00 83,283,336.00 79,841,774.00 80,157,271.00 - 76,907,964.00 74,380,054.00 74,463,925.00
DEI Earnings Per Adjusted Shares Outstanding
0.52 -1.65 -2.83 -2.31 -2.60 2.65 -0.27 - -0.93 6.81 -9.23
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-42.42% -42.93% -42.23% 286.03% -22.84% -7.48% -8.13% -10.46% -12.21% -1.47% -3.64%
EBITDA Growth
315.98% 46.08% -27.43% 179.83% 300.04% -53.28% -109.93% -159.01% -99.42% -8.71% 1,513.94%
EBIT Growth
70.41% 164.36% 354.46% 302.69% 195.94% -88.12% -309.58% -259.67% -181.80% 20.46% 499.90%
NOPAT Growth
67.81% 61.26% 124.88% 408.32% 151.68% 102.94% -350.41% 9,991.08% -266.08% -96.99% 88.82%
Net Income Growth
-89.17% -54.39% 39.43% -161.04% -577.11% 248.89% 90.85% 61.99% 67.06% 141.10% -3,051.58%
EPS Growth
-88.84% -59.81% 37.92% -156.32% -617.65% 250.29% 90.79% 59.32% 64.39% 159.92% -3,288.89%
Operating Cash Flow Growth
59.85% -80.67% 345.24% 204.46% -106.70% -113.82% -52.95% -46.40% 671.20% -1,068.76% 71.75%
Free Cash Flow Firm Growth
1,530.41% 849.92% 5,449.38% 241.56% -67.68% -65.47% -60.31% 148.70% -36.16% -25.05% -52.09%
Invested Capital Growth
-46.69% -45.97% -43.12% -34.82% -27.58% -29.23% -30.53% -7.71% -25.74% -31.20% -20.78%
Revenue Q/Q Growth
-41.00% 1.62% 1.20% 12.37% -33.23% 2.88% 0.49% 9.53% -34.53% 3.27% -1.35%
EBITDA Q/Q Growth
-87.55% 355.41% -14.38% 53.73% -33.26% -55.93% -118.19% -813.84% 100.65% 5,951.19% 825.73%
EBIT Q/Q Growth
0.55% 186.51% -35.29% 201.10% -43.08% -92.17% -1,241.23% -129.40% 70.84% 85.62% 4,992.18%
NOPAT Q/Q Growth
-18.85% 53.96% 137.91% 490.30% -49.83% -98.23% -3,326.44% 23,888.59% -100.83% 62.11% 79.93%
Net Income Q/Q Growth
-86.23% -414.57% -67.84% 16.03% -7.61% 198.17% -110.32% -248.71% 6.77% 818.61% -234.90%
EPS Q/Q Growth
-87.83% -435.29% -71.35% 19.45% -11.86% 197.35% -110.51% -255.56% 2.08% 810.64% -236.98%
Operating Cash Flow Q/Q Growth
-14.19% -50.47% 221.54% 6.51% -103.95% -2.19% 1,194.70% 21.33% -57.93% -169.13% 336.52%
Free Cash Flow Firm Q/Q Growth
701.44% -2.25% -10.40% -49.36% -27.12% 3.62% 2.98% 217.33% -81.29% 21.95% -34.10%
Invested Capital Q/Q Growth
-7.32% 0.09% -0.12% -29.65% 2.97% -2.19% -1.95% -6.55% -17.14% -9.39% 12.90%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.44% 60.06% 62.14% 65.83% 61.11% 65.59% 64.83% 69.80% 62.22% 64.16% 63.86%
EBITDA Margin
2.62% 11.74% 9.93% 13.59% 13.58% 5.93% -1.07% -8.95% 0.09% 5.22% 49.02%
Operating Margin
-10.16% -3.39% 1.27% 6.67% 5.01% 0.10% -3.46% -17.55% -9.47% -3.27% -0.71%
EBIT Margin
-5.30% 4.51% 2.89% 7.73% 6.59% 0.58% -6.58% -13.79% -6.14% -0.86% 42.41%
Profit (Net Income) Margin
7.20% -22.30% -36.99% -27.64% -44.55% 35.89% -3.69% -11.73% -16.71% 116.28% -159.01%
Tax Burden Percent
46.86% 76.42% 65.52% 75.67% 66.88% 76.97% 44.36% -2,997.15% 396.35% 73.38% 71.12%
Interest Burden Percent
-289.94% -646.52% -1,955.74% -472.25% -1,010.28% 8,042.11% 126.16% -2.84% 68.64% -18,529.64% -527.17%
Effective Tax Rate
48.48% 0.00% 0.00% 0.00% 0.00% 23.03% 0.00% 3,096.13% 0.00% 25.63% 0.00%
Return on Invested Capital (ROIC)
-3.78% -1.51% 0.51% 3.65% 2.68% 0.09% -2.77% 494.33% -6.52% -2.52% -0.49%
ROIC Less NNEP Spread (ROIC-NNEP)
-9.00% 7.53% 19.59% 10.95% 11.72% -7.92% -2.47% 610.03% -4.67% -21.06% 29.17%
Return on Net Nonoperating Assets (RNNOA)
1.94% -1.56% -3.86% -5.34% -5.17% 3.56% 1.08% -330.06% 2.30% 11.67% -14.46%
Return on Equity (ROE)
-1.84% -3.07% -3.35% -1.69% -2.49% 3.64% -1.69% 164.27% -4.22% 9.15% -14.95%
Cash Return on Invested Capital (CROIC)
58.47% 57.67% 53.44% 41.56% 33.26% 36.78% 37.97% 5.34% 25.25% 31.62% 18.89%
Operating Return on Assets (OROA)
-1.96% 1.49% 0.86% 2.02% 1.86% 0.24% -2.83% -3.92% -2.05% -0.27% 14.26%
Return on Assets (ROA)
2.66% -7.37% -11.02% -7.23% -12.59% 15.14% -1.58% -3.34% -5.57% 36.38% -53.47%
Return on Common Equity (ROCE)
-1.65% -2.75% -2.98% -1.51% -2.33% 3.40% -1.58% 152.69% -4.18% 9.06% -14.77%
Return on Equity Simple (ROE_SIMPLE)
-1.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-33 -15 5.70 34 17 0.44 -14 3,397 -28 -11 -2.13
NOPAT Margin
-5.23% -2.37% 0.89% 4.67% 3.51% 0.08% -2.42% 525.82% -6.63% -2.43% -0.50%
Net Nonoperating Expense Percent (NNEP)
5.23% -9.05% -19.09% -7.30% -9.04% 8.00% -0.30% -115.71% -1.85% 18.55% -29.66%
Return On Investment Capital (ROIC_SIMPLE)
-0.37% -0.17% 0.07% 0.43% 0.27% 0.01% -0.23% 54.88% -0.47% -0.16% -0.04%
Cost of Revenue to Revenue
41.56% 39.94% 37.86% 34.17% 38.89% 34.41% 35.17% 30.20% 37.78% 35.84% 36.14%
SG&A Expenses to Revenue
20.42% 19.86% 16.95% 18.96% 9.03% 19.99% 22.44% 16.41% 24.62% 26.00% 22.41%
R&D to Revenue
10.13% 8.41% 8.40% 8.01% 7.42% 8.49% 8.39% 7.20% 9.39% 7.71% 7.97%
Operating Expenses to Revenue
68.60% 63.45% 60.87% 59.16% 56.10% 65.49% 68.28% 87.35% 71.69% 67.43% 64.57%
Earnings before Interest and Taxes (EBIT)
-33 29 19 56 32 3.40 -39 -89 -26 -3.74 183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
16 74 64 98 65 35 -6.33 -58 0.38 23 211
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.62 0.56 0.67 0.55 0.67 0.61 0.57 0.64 0.68 0.68 0.71
Price to Tangible Book Value (P/TBV)
1.57 1.43 1.81 1.02 1.45 1.24 1.18 1.22 1.15 1.07 1.23
Price to Revenue (P/Rev)
0.97 0.97 1.30 1.18 1.28 0.80 0.75 1.27 1.32 1.47 1.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 75.28 10.21 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 21.14% 23.17% 20.18% 19.72% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.33% 9.79% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.38 0.29 0.49 0.46 0.43 0.28 0.21 0.30 0.27 0.10 0.39
Enterprise Value to Revenue (EV/Rev)
0.37 0.32 0.62 0.46 0.48 0.20 0.15 0.31 0.24 0.08 0.35
Enterprise Value to EBITDA (EV/EBITDA)
4.99 3.55 6.44 4.81 3.92 1.81 1.65 14.88 0.00 0.00 3.85
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 17.40 8.77 4.49 5.21 0.00 0.00 0.00 8.86
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 28.68 9.00 8.97 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
6.99 9.06 10.77 6.32 7.90 2.55 2.18 12.03 6.98 2.71 10.27
Enterprise Value to Free Cash Flow (EV/FCFF)
0.45 0.36 0.66 0.87 1.09 0.62 0.46 5.42 0.92 0.26 1.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.29 0.30 0.31 0.23 0.31 0.29 0.30 0.30 0.31 0.28 0.32
Long-Term Debt to Equity
0.29 0.29 0.30 0.23 0.30 0.28 0.29 0.29 0.30 0.27 0.31
Financial Leverage
-0.22 -0.21 -0.20 -0.49 -0.44 -0.45 -0.44 -0.54 -0.49 -0.55 -0.50
Leverage Ratio
1.53 1.53 1.54 1.53 1.51 1.50 1.50 1.52 1.50 1.47 1.48
Compound Leverage Factor
-4.44 -9.91 -30.03 -7.24 -15.27 120.86 1.90 -0.04 1.03 -273.19 -7.80
Debt to Total Capital
22.74% 23.01% 23.60% 18.91% 23.49% 22.41% 22.79% 22.94% 23.61% 21.62% 24.06%
Short-Term Debt to Total Capital
0.39% 0.44% 0.51% 0.45% 0.68% 0.33% 0.36% 0.39% 0.41% 0.37% 0.42%
Long-Term Debt to Total Capital
22.36% 22.57% 23.10% 18.46% 22.81% 22.08% 22.43% 22.55% 23.21% 21.24% 23.64%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
8.08% 8.21% 8.52% 9.34% 0.79% 0.81% 0.85% 0.89% 0.75% 0.73% 0.97%
Common Equity to Total Capital
69.17% 68.78% 67.87% 71.75% 75.72% 76.78% 76.36% 76.17% 75.64% 77.65% 74.97%
Debt to EBITDA
7.04 6.48 7.01 5.82 4.85 3.52 4.24 28.77 -91.81 -80.17 6.76
Net Debt to EBITDA
-10.76 -9.54 -9.51 -10.26 -6.75 -5.64 -6.62 -47.32 166.12 186.87 -11.41
Long-Term Debt to EBITDA
6.92 6.36 6.85 5.68 4.71 3.47 4.18 28.27 -90.22 -78.78 6.64
Debt to NOPAT
-15.28 -18.57 -25.16 -73.23 35.48 17.50 23.08 -20.91 -13.95 -11.75 -13.96
Net Debt to NOPAT
23.37 27.32 34.16 129.17 -49.42 -28.03 -35.98 34.40 25.23 27.40 23.57
Long-Term Debt to NOPAT
-15.01 -18.21 -24.62 -71.48 34.45 17.24 22.71 -20.55 -13.70 -11.55 -13.72
Altman Z-Score
1.19 1.08 1.13 0.96 1.17 1.32 1.23 1.11 1.21 1.31 1.38
Noncontrolling Interest Sharing Ratio
10.13% 10.43% 11.05% 10.98% 6.60% 6.58% 6.85% 7.05% 1.01% 0.99% 1.18%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.70 2.68 2.75 2.80 2.70 2.87 2.56 2.75 3.69 3.69 4.01
Quick Ratio
2.46 2.46 2.54 2.10 2.47 2.63 2.37 2.51 3.43 3.43 3.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,265 3,191 2,859 1,448 1,055 1,102 1,135 3,601 674 822 541
Operating Cash Flow to CapEx
0.00% 595.34% 1,881.64% 1,299.52% -65.14% -63.46% 3,461.31% 0.00% 193.29% -95.08% 406.51%
Free Cash Flow to Firm to Interest Expense
94.14 92.57 82.50 45.38 37.27 29.65 41.06 133.81 26.05 31.76 20.78
Operating Cash Flow to Interest Expense
1.16 0.58 1.85 2.14 -0.10 -0.07 1.09 1.36 0.60 -0.41 0.97
Operating Cash Flow Less CapEx to Interest Expense
1.44 0.48 1.75 1.97 -0.24 -0.19 1.06 1.66 0.29 -0.84 0.73
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.37 0.33 0.30 0.26 0.28 0.42 0.43 0.28 0.33 0.31 0.34
Accounts Receivable Turnover
7.80 6.78 5.93 5.14 5.80 8.56 8.35 5.14 6.48 6.60 6.30
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
8.81 7.59 6.73 6.82 6.77 10.38 10.44 7.97 7.87 7.84 7.91
Accounts Payable Turnover
12.68 11.34 9.48 12.59 14.22 15.30 14.96 17.76 18.89 19.43 19.68
Days Sales Outstanding (DSO)
46.81 53.85 61.50 70.97 62.97 42.65 43.71 71.06 56.33 55.31 57.91
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
28.79 32.18 38.51 28.98 25.67 23.86 24.39 20.55 19.32 18.79 18.55
Cash Conversion Cycle (CCC)
18.03 21.67 22.99 41.99 37.30 18.79 19.32 50.51 37.01 36.53 39.36
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,765 3,768 3,764 2,648 2,726 2,667 2,615 2,444 2,025 1,835 2,071
Invested Capital Turnover
0.72 0.64 0.57 0.78 0.76 1.15 1.15 0.94 0.98 1.03 0.99
Increase / (Decrease) in Invested Capital
-3,297 -3,206 -2,854 -1,414 -1,038 -1,101 -1,149 -204 -702 -832 -544
Enterprise Value (EV)
1,430 1,100 1,843 1,216 1,182 737 555 737 554 183 803
Market Capitalization
3,798 3,341 3,839 3,082 3,169 2,981 2,731 3,028 3,079 3,433 3,125
Book Value per Share
$71.34 $69.79 $66.88 $64.66 $56.60 $61.51 $59.76 $61.13 $59.15 $68.33 $58.97
Tangible Book Value per Share
$28.19 $27.14 $24.62 $35.12 $26.29 $30.19 $28.86 $31.98 $34.67 $43.25 $34.17
Total Capital
8,866 8,735 8,486 7,774 6,225 6,396 6,273 6,215 6,015 6,545 5,857
Total Debt
2,017 2,010 2,003 1,470 1,462 1,433 1,430 1,426 1,420 1,415 1,409
Total Long-Term Debt
1,982 1,971 1,960 1,435 1,420 1,412 1,407 1,401 1,396 1,390 1,385
Net Debt
-3,085 -2,957 -2,719 -2,593 -2,036 -2,296 -2,229 -2,345 -2,570 -3,298 -2,379
Capital Expenditures (CapEx)
-9.74 3.35 3.41 5.25 4.14 4.34 0.87 -7.99 7.96 11 6.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-153 -167 -175 252 -51 -30 -59 48 43 43 23
Debt-free Net Working Capital (DFNWC)
1,490 1,522 1,570 1,634 1,109 1,064 947 1,008 1,155 1,156 1,342
Net Working Capital (NWC)
1,456 1,483 1,526 1,599 1,066 1,043 924 984 1,131 1,131 1,318
Net Nonoperating Expense (NNE)
-78 126 243 233 231 -210 7.46 3,472 43 -518 683
Net Nonoperating Obligations (NNO)
-3,085 -2,957 -2,719 -3,657 -2,036 -2,296 -2,229 -2,345 -2,570 -3,295 -2,377
Total Depreciation and Amortization (D&A)
49 46 45 42 34 31 33 31 26 27 28
Debt-free, Cash-free Net Working Capital to Revenue
-3.93% -4.87% -5.92% 9.61% -2.04% -0.81% -1.61% 2.01% 1.84% 1.84% 1.01%
Debt-free Net Working Capital to Revenue
38.16% 44.40% 53.05% 62.31% 44.71% 28.71% 25.91% 42.14% 49.49% 49.65% 58.06%
Net Working Capital to Revenue
37.28% 43.27% 51.59% 60.98% 43.01% 28.14% 25.28% 41.11% 48.44% 48.60% 57.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 ($1.71) ($2.93) ($2.37) ($2.64) $2.64 ($0.27) ($1.03) ($0.94) $6.78 ($9.15)
Adjusted Weighted Average Basic Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M
Adjusted Diluted Earnings per Share
$0.51 ($1.71) ($2.93) ($2.36) ($2.64) $2.57 ($0.27) ($0.96) ($0.94) $6.68 ($9.15)
Adjusted Weighted Average Diluted Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
86.09M 86.12M 86.27M 83.28M 79.84M 80.16M 77.43M 76.91M 74.38M 74.46M 75.04M
Normalized Net Operating Profit after Tax (NOPAT)
-33 -15 5.70 34 17 0.44 -14 -79 -28 -11 -2.13
Normalized NOPAT Margin
-5.23% -2.37% 0.89% 4.67% 3.51% 0.08% -2.42% -12.29% -6.63% -2.43% -0.50%
Pre Tax Income Margin
15.37% -29.18% -56.45% -36.52% -66.60% 46.63% -8.31% 0.39% -4.22% 158.47% -223.59%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.95 0.83 0.53 1.75 1.12 0.09 -1.41 -3.31 -1.00 -0.14 7.01
NOPAT to Interest Expense
-0.94 -0.44 0.16 1.05 0.60 0.01 -0.52 126.22 -1.08 -0.41 -0.08
EBIT Less CapEx to Interest Expense
-0.67 0.73 0.44 1.58 0.98 -0.03 -1.44 -3.01 -1.31 -0.58 6.78
NOPAT Less CapEx to Interest Expense
-0.66 -0.53 0.07 0.89 0.45 -0.10 -0.55 126.52 -1.39 -0.84 -0.32
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-81.97% -4.66% -103.36% 0.00% -22.63% -51.86% -146.01% -310.48% 610.97% 73.11% -45.81%

Financials Breakdown Chart

Key Financial Trends

People Incorporated (NASDAQ:PPLI) reported a sharply improved Q2 2026 earnings quarter, although the results were driven primarily by investment income rather than stronger operating performance. The supplied filings identify the company as IAC Inc., so investors should verify the ticker and company mapping before relying on these figures.

Revenue and profitability: Q2 2026 revenue was $436.7 million, down 1.5% from $443.2 million in the restated Q2 2025 and well below the $642.0 million reported in Q3 2024. Gross profit declined modestly year over year to $280.2 million, while the gross margin improved slightly to approximately 64.2% from 63.7%. Operating expenses rose to $294.5 million, producing an operating loss of $14.3 million. This was an improvement from the $40.1 million operating loss in Q1 2026, but operating profitability remains negative.

Net income benefited from investment gains: Interest and investment income surged to $721.7 million in Q2 2026 from $34.0 million in Q1 and $307.4 million in the restated year-ago quarter. As a result, net income attributable to common shareholders reached $506.9 million, or $6.78 per diluted share, compared with a $71.9 million loss, or negative $0.94 per share, in Q1 2026. The magnitude and volatility of this income stream make reported earnings less representative of recurring operating performance.

Cash flow and balance sheet: Operating cash flow was negative $10.6 million in Q2 2026, despite the sizable accounting profit. Continuing operations generated $45.7 million of operating cash flow, but discontinued operations and other adjustments reduced the consolidated figure. Cash declined by $50.4 million during the quarter to $1.11 billion. The company retained substantial liquidity, with current assets of $1.55 billion versus current liabilities of $420.4 million, while total debt was approximately $1.42 billion.

  • Net income attributable to common shareholders increased to $506.9 million from a $71.9 million loss in Q1 2026 and $211.5 million in restated Q2 2025.
  • Diluted EPS improved to $6.68 from negative $0.94 in Q1 2026 and $2.57 in restated Q2 2025.
  • Operating losses narrowed sequentially to $14.3 million from $40.1 million in Q1 2026, helped by higher revenue and lower marketing and research expenses.
  • The balance sheet remained liquid, with approximately $1.11 billion of cash and a current ratio of roughly 3.7.
  • Total liabilities declined to $2.39 billion from $2.43 billion in Q1 2025, while common equity increased to $5.08 billion from $4.91 billion in Q2 2025.
  • Long-term investments rose sharply to $3.60 billion from $2.88 billion in Q1 2026, making asset values and earnings more sensitive to investment-market performance.
  • Weighted-average diluted shares declined approximately 7.1% year over year to 74.5 million, reflecting ongoing share repurchases and supporting per-share results.
  • Q2 2025 and Q1 2025 income statements were restated, and the supplied company name does not match the stated PPLI ticker; investors should confirm the underlying filings.
  • Revenue fell 1.5% year over year, and operating income remained negative despite the large improvement in reported net income.
  • Consolidated operating cash flow was negative $10.6 million in Q2 2026, while net cash fell $50.4 million after investing, financing and other cash outflows.

Overall, the latest quarter shows improved reported earnings, strong liquidity and continued share-count reduction. However, the core business has not yet returned to operating profitability, and the quarter’s earnings were dominated by unusually high investment income. Retail investors should place greater emphasis on operating margins, recurring cash generation and the sustainability of investment returns in future quarters.

11/19/26 02:57 PM ETAI Generated. May Contain Errors.

People Incorporated Common Stock Financials - Frequently Asked Questions

According to the most recent income statement we have on file, People Incorporated Common Stock's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

People Incorporated Common Stock's net income appears to be on a downward trend, with a most recent value of -$101.47 million in 2025, compared with $292.37 million in 2018. The previous period was -$533.33 million in 2024. Find out what analysts predict for People Incorporated Common Stock in the coming months.

People Incorporated Common Stock's total operating income in 2025 was -$97.42 million, based on the following breakdown:
  • Total Gross Profit: $1.58 billion
  • Total Operating Expenses: $1.68 billion

Over the last 7 years, People Incorporated Common Stock's total revenue changed from $2.53 billion in 2018 to $2.39 billion in 2025, a change of -5.5%.

In the past 13 quarters, People Incorporated Common Stock's cash and equivalents has ranged from $1.01 billion in Q3 2025 to $1.72 billion in Q3 2024, and is currently $1.32 billion as of their latest financial filing in Q3 2026.

People Incorporated Common Stock had total debt of $1.43 billion at the end of 2025, a 3.0% decrease from 2024, and none in 2018.

Over the last 7 years, People Incorporated Common Stock's book value per share changed from 0.00 in 2018 to 61.13 in 2025, a change of 6,113.5%.



Financial statements for NASDAQ:PPLI last updated on 11/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners